Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Killen

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitisJ A Killen, R H Swanborg
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugatesJ A Killen, J M Lindstrom
Journal of Neuroimmunology|October 1, 1982
Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cellsJ A Killen, R H Swanborg
Immunological Communications|January 1, 1982
Helix pomatia receptors on rat T lymphocytes and bone marrow cellsJ A Killen, J H Holda, R H Swanborg
Journal of Neuroimmunology|April 1, 1988
Central catecholamine neurotoxin administration. 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitisW J Karpus, R J Konkol, J A Killen
Advances in Experimental Medicine and Biology|January 1, 1982
Autoimmunity to myelin basic proteinR H Swanborg, J H Holda, J A Killen
Journal of Neuroimmunology|August 1, 1985
The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotypeJ A Killen, S M Hochschwender, J M Lindstrom
Journal of Neuroimmunology|January 1, 1990
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamineR J Konkol, U Wesselmann, W J Karpus, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1982
Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitisJ A Killen, R H Swanborg
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 1984
Specific killing of lymphocytes that cause experimental autoimmune myasthenia gravis by ricin toxin-acetylcholine receptor conjugatesJ A Killen, J M Lindstrom
Journal of Neuroimmunology|October 1, 1982
Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cellsJ A Killen, R H Swanborg
Immunological Communications|January 1, 1982
Helix pomatia receptors on rat T lymphocytes and bone marrow cellsJ A Killen, J H Holda, R H Swanborg
Journal of Neuroimmunology|April 1, 1988
Central catecholamine neurotoxin administration. 1. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitisW J Karpus, R J Konkol, J A Killen
Advances in Experimental Medicine and Biology|January 1, 1982
Autoimmunity to myelin basic proteinR H Swanborg, J H Holda, J A Killen
Journal of Neuroimmunology|August 1, 1985
The main immunogenic region of acetylcholine receptors does not provoke the formation of antibodies of a predominant idiotypeJ A Killen, S M Hochschwender, J M Lindstrom
Journal of Neuroimmunology|January 1, 1990
Suppression of clinical weakness in experimental autoimmune encephalomyelitis associated with weight changes, and post-decapitation convulsions after intracisternal-ventricular administration of 6-hydroxydopamineR J Konkol, U Wesselmann, W J Karpus, et al.
Pageof 1